Bronze Sponsor

“CALIXAR’s patented technology (8 patents families, 28 publications) enables the isolation in solution of fully native and functional antigens for vaccine discovery.
Our development is based on the inactivation of virus by splitting the viral envelope while keeping the native structural protein complexes. Thanks to our innovative proprietary surfactant and detergent, we obtain an efficient virus splitting. The produced antigens show a high recognition of specific antibodies and generate strong immune responses.”